Chen Yang, Qin Xiao-Lin, Zhou Han, Wu Xing-Zhong, Chen Wen-Tao, Zhang Zi-Yan, Zhan Qing-Xian, Feng Zhan-Qin, Xue Yao-Hua, Hu Yong-Fei, Guo Chi-Xing, Wang Feng, Li Ming, Wu Zhi-Zhou, Xie Jian-Hong, Liang Lian-Hui, Xiao Hui-Xuan, Shi Zheng-Qi, Hu Xue-Mei, Li Qian, Chen He-Yong, Ke Yong-Jian, Luo Wen-Ying, Huang Guan-Jun, Huang Jin-Bo, Peng Ying, Zheng He-Ping
Dermatology Hospital, Southern Medical University, Guangzhou, China.
Dermatology Hospital, Southern Medical University, Guangzhou, China; Guangzhou Key Laboratory for Sexually Transmitted Diseases Control, Guangzhou, China.
J Glob Antimicrob Resist. 2025 Jul 16;44:287-296. doi: 10.1016/j.jgar.2025.07.005.
This study aimed to investigate the molecular characteristics of predominant epidemic clusters of FC428-like N. gonorrhoeae in Guangdong, China in 2022.
Minimum inhibitory concentrations (MICs) were determined for N. gonorrhoeae isolates collected from the Guangdong Gonococcal Antimicrobial Surveillance Program. N. gonorrhoeae multiantigen sequence typing (NG-MAST), antimicrobial resistance sequence typing (NG-STAR), multilocus sequence typing (MLST) sequence types (STs), and penA alleles were determined by whole-genome sequencing. The isolates were further characterised by phylogenetic analysis.
A total of 537 N. gonorrhoeae isolates were analysed, molecular analysis revealed that 7.8% of the isolates carried penA 60.001 allele, which was highly resistant to ceftriaxone (88.1%) and cefixime (100.0%). The predominant STs in penA 60.001 isolates were MLST ST1903 (23,54.8%), ST7365 (11,26.2%), NG-STAR ST1143 (13,31.0%), ST233 (4,9.5%), ST1133 (4,9.5%), and NG-MAST ST22261 (10,23.8%). Among 537 isolates, of which 11.2% were resistant to ceftriaxone and 19.6% to cefixime. In western Guangdong, resistance to ceftriaxone and cefixime reached 17.3% and 26.9%, respectively. The most predominant types among ceftriaxone-resistant isolates are genetically closer to FC428 isolates, and differ from those among cefixime-resistant isolates. Phylogenetic analysis revealed that the Guangdong FC428-like isolates from 2021 to 2022 spread across the whole phylogenetic tree, but the majority were clustered within a distinct evolutionary clade.
FC428-like isolates in Guangdong formed a unique evolutionary clade with high cephalosporin resistance. These findings highlight the need to revise national gonorrhea treatment guidelines and prioritise the development of new antimicrobials.
本研究旨在调查2022年中国广东省FC428样淋病奈瑟菌主要流行集群的分子特征。
对从广东省淋球菌抗菌药物监测项目收集的淋病奈瑟菌分离株进行最低抑菌浓度(MIC)测定。通过全基因组测序确定淋病奈瑟菌多抗原序列分型(NG-MAST)、抗菌药物耐药序列分型(NG-STAR)、多位点序列分型(MLST)序列类型(STs)和penA等位基因。通过系统发育分析对分离株进行进一步表征。
共分析了537株淋病奈瑟菌分离株,分子分析显示7.8%的分离株携带penA 60.001等位基因,对头孢曲松(88.1%)和头孢克肟(100.0%)高度耐药。penA 60.001分离株中的主要STs为MLST ST1903(23株,54.8%)、ST7365(11株,26.2%)、NG-STAR ST1143(13株,31.0%)、ST233(4株,9.5%)、ST1133(4株,9.5%)和NG-MAST ST22261(10株,23.8%)。在537株分离株中,11.2%对头孢曲松耐药,19.6%对头孢克肟耐药。在广东省西部,对头孢曲松和头孢克肟的耐药率分别达到17.3%和26.9%。头孢曲松耐药分离株中最主要的类型在基因上更接近FC428分离株,与头孢克肟耐药分离株中的类型不同。系统发育分析显示,2021年至2022年广东省FC428样分离株分布在整个系统发育树中,但大多数聚集在一个独特的进化分支内。
广东省FC428样分离株形成了一个具有高头孢菌素耐药性的独特进化分支。这些发现凸显了修订国家淋病治疗指南以及优先开发新型抗菌药物的必要性。